Obstructive sleep apnea in obesity: Difference between revisions

Nav

[unchecked revision]

Revision as of 04:02, 23 May 2026 view source MDElliottMD (talk \| contribs) Bureaucrats, Interface administrators, Administrators 5,664 edits Auto-create stub from pcp_problem migration		Latest revision as of 06:03, 13 June 2026 view source MDElliottMD (talk \| contribs) Bureaucrats, Interface administrators, Administrators 5,664 edits Launch A7: honest early-note placeholder (mark-tapped)
Line 1:		Line 1:
	~~''Stub.'' A short~~ clinical description ~~of '''Obstructive sleep apnea in obesity''' goes here~~.		<span class="pcp-early-note">This page is early; a full clinical description is coming. The cross-linked medicines below are live.</span>

	Moderate-to-severe obstructive sleep apnea in adults with obesity. Basis for the 2024 tirzepatide (Zepbound) OSA approval following SURMOUNT-OSA.		Moderate-to-severe obstructive sleep apnea in adults with obesity. Basis for the 2024 tirzepatide (Zepbound) OSA approval following SURMOUNT-OSA.